Cheng-I Liao

844 total citations · 1 hit paper
45 papers, 493 citations indexed

About

Cheng-I Liao is a scholar working on Obstetrics and Gynecology, Oncology and Reproductive Medicine. According to data from OpenAlex, Cheng-I Liao has authored 45 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Obstetrics and Gynecology, 16 papers in Oncology and 14 papers in Reproductive Medicine. Recurrent topics in Cheng-I Liao's work include Endometrial and Cervical Cancer Treatments (21 papers), Ovarian cancer diagnosis and treatment (11 papers) and Cervical Cancer and HPV Research (10 papers). Cheng-I Liao is often cited by papers focused on Endometrial and Cervical Cancer Treatments (21 papers), Ovarian cancer diagnosis and treatment (11 papers) and Cervical Cancer and HPV Research (10 papers). Cheng-I Liao collaborates with scholars based in Taiwan, United States and South Korea. Cheng-I Liao's co-authors include John K. Chan, Daniel S. Kapp, Amandeep Mann, Warner K. Huh, Chun-Hao Yin, Ching‐Chih Lee, Chunqiao Tian, Kathleen M. Darcy, Chyi-Uei Chern and Yu‐Ligh Liou and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and American Journal of Obstetrics and Gynecology.

In The Last Decade

Cheng-I Liao

39 papers receiving 484 citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trends in Human Papillomavirus–Associated Cancers, Demographic Characteristics, and Vaccinations in the US, 2001-2017

2022 94 citations Cheng-I Liao, Daniel S. Kapp et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheng-I Liao Taiwan	10	213	157	120	109	102	45	493
Eun Young Ki South Korea	12	145 0.7×	138 0.9×	122 1.0×	111 1.0×	171 1.7×	29	414
Tomomi Egawa‐Takata Japan	14	206 1.0×	149 0.9×	128 1.1×	123 1.1×	89 0.9×	39	517
Jennifer K. Burzawa United States	18	222 1.0×	255 1.6×	306 2.5×	185 1.7×	102 1.0×	40	806
Swee Peng Yap Singapore	11	38 0.2×	60 0.4×	187 1.6×	39 0.4×	96 0.9×	23	372
Margaux J. Kanis United States	12	94 0.4×	268 1.7×	134 1.1×	192 1.8×	95 0.9×	44	472
Lee Alexander Grant United Kingdom	13	110 0.5×	64 0.4×	97 0.8×	76 0.7×	257 2.5×	29	494
James S. Tomlinson United States	8	175 0.8×	35 0.2×	236 2.0×	77 0.7×	65 0.6×	16	408
Maria B. Schiavone United States	10	68 0.3×	290 1.8×	99 0.8×	284 2.6×	219 2.1×	23	538
Roberto Almeida Gil Brazil	6	90 0.4×	149 0.9×	53 0.4×	39 0.4×	259 2.5×	8	397
Jason Yap United Kingdom	10	88 0.4×	300 1.9×	89 0.7×	238 2.2×	113 1.1×	34	523

Countries citing papers authored by Cheng-I Liao

Since Specialization

Citations

This map shows the geographic impact of Cheng-I Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng-I Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng-I Liao more than expected).

Fields of papers citing papers by Cheng-I Liao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng-I Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng-I Liao. The network helps show where Cheng-I Liao may publish in the future.

Co-authorship network of co-authors of Cheng-I Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng-I Liao. A scholar is included among the top collaborators of Cheng-I Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng-I Liao. Cheng-I Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liao, Cheng-I, Jih-Heng Chen, Chao‐Chun Yang, et al.. (2025). Enhanced stability, antioxidant capacity and in vivo anti-inflammatory efficacy of glutathione and quercetin via nanoemulsion formulation. Journal of the Taiwan Institute of Chemical Engineers. 168. 105943–105943. 2 indexed citations

Kung, Chung‐Wei, Po‐Ting Chen, Huey‐Jen Su, et al.. (2025). Enhancing biomass and lipid production in Chlorella sorokiniana via magnesium metal-organic framework of Mg-MOF-74. Journal of the Taiwan Institute of Chemical Engineers. 178. 106405–106405.

Liang, Chunmei, et al.. (2025). The effect of virtual reality on pregnant women and fetuses: a systematic review and meta-analysis of randomized controlled trials. Archives of Gynecology and Obstetrics. 312(2). 337–350. 1 indexed citations

Liao, Cheng-I, Jenny Chang, Krishnansu S. Tewari, et al.. (2024). Endometrial cancer and obesity trends in the United States in the 21st century.. Journal of Clinical Oncology. 42(16_suppl). 5507–5507. 1 indexed citations

Liao, Cheng-I, et al.. (2024). Increase in uterine cancer incidence among Black patients in the United States: A United States Cancer Statistics Study of nearly 95,000 patients from 2001 to 2019. Gynecologic Oncology. 190. S73–S74. 1 indexed citations

Liao, Cheng-I, Chunqiao Tian, Michael Richardson, et al.. (2024). Uterine cancer among Asian Americans – Disparities & clinical characteristics. Gynecologic Oncology. 182. 24–31. 5 indexed citations

Liao, Cheng-I, et al.. (2023). The impact of climate change on cancer incidence in U.S. women: Who is most affected?. Journal of Clinical Oncology. 41(16_suppl). 10525–10525.

Liao, Cheng-I, Hua‐Chang Fang, Po‐Tsang Lee, et al.. (2023). Trends in the incidence of urothelial carcinoma in Taiwan after the ban on aristolochic acid-containing Chinese herbal preparations, 2001–2018: a national population-based cohort study. Journal of Cancer Research and Clinical Oncology. 149(11). 8201–8211. 8 indexed citations

Liao, Cheng-I, et al.. (2022). The increasing incidence of stage IV cervical cancer in the USA: what factors are related?. International Journal of Gynecological Cancer. 32(9). 1115–1122. 37 indexed citations

10.

Liao, Cheng-I, Danny Lee, Kathleen M. Darcy, et al.. (2022). Increasing incidence of uterine carcinosarcoma: A United States Cancer Statistics study. Gynecologic Oncology Reports. 40. 100936–100936. 7 indexed citations

11.

Tian, Chunqiao, Yovanni Casablanca, Nicholas W. Bateman, et al.. (2021). Histologic disparities in uterine cancer diagnosis by race/ethnicity and country of origin. Gynecologic Oncology. 162. S170–S171.

12.

Liao, Cheng-I, Ken Y. Lin, Kathleen M. Darcy, et al.. (2021). Racial disparities in the incidence of vulvar cancer in the United States: a study of 75,767 over 16 years. Gynecologic Oncology. 162. S251–S251. 2 indexed citations

13.

Richardson, Michael, David Mysona, David A. Klein, et al.. (2020). Long term survival outcomes of stage I mucinous ovarian cancer - A clinical calculator predictive of chemotherapy benefit. Gynecologic Oncology. 159(1). 118–128. 8 indexed citations

14.

Abel, Mary Kathryn, John K. Chan, Stephanie Chow, et al.. (2020). Trends and survival outcomes of robotic, laparoscopic, and open surgery for stage II uterine cancer. International Journal of Gynecological Cancer. 30(9). 1347–1355. 12 indexed citations

15.

Chow, Stephanie, Deanna H. Wong, Cheng-I Liao, et al.. (2020). Uterine clear cell carcinoma risk in White versus non-White US subpopulations: does race matter?. Journal of Gynecologic Oncology. 31(6). e81–e81. 3 indexed citations

16.

Gardner, Austin B., et al.. (2019). The association of marital status, socioeconomic status, and race on the survival of ovarian cancer patients.. Journal of Clinical Oncology. 37(15_suppl). e17056–e17056. 1 indexed citations

17.

Klein, David A., Amandeep Mann, A.H. Freeman, et al.. (2019). Chemotherapy alone for patients 75 years and older with epithelial ovarian cancer—is interval cytoreductive surgery still needed?. American Journal of Obstetrics and Gynecology. 222(2). 170.e1–170.e11. 8 indexed citations

18.

Liao, Cheng-I, Stephanie Chow, Lee-may Chen, et al.. (2018). Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US. Gynecologic Oncology. 149(2). 318–323. 40 indexed citations

19.

Liou, Yu‐Ligh, et al.. (2014). PAX1 Methylation as a Potential Biomarker for Cervical Cancer Screening. International Journal of Gynecological Cancer. 24(5). 928–934. 62 indexed citations

20.

Liao, Cheng-I, et al.. (2005). “Silent” rupture of unscarred gravid uterus with subsequent pelvic abscess: Successful laparoscopic management. Journal of Minimally Invasive Gynecology. 12(6). 519–521. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact